US Edition
Published • loading... • Updated
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium - InflaRx (NASDAQ:
Summary by Benzinga
1 Articles
1 Articles
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium - InflaRx (NASDAQ:
JENA, Germany, March 31, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in the Raymond James 2026 Biotech Innovation Symposium. Details are as follows: Raymond James 2026 Biotech Innovation SymposiumApril 14, 2026, in New York, NYThe Company will hold one-on-one investor meetings. About InflaRxInflaR…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
